Wilsons have been negative on LVT ever since they missed out on being part of a cap raise about 18 months ago. Their analyst on the stock has no idea. I’ve got a research report from them valuing LVT at $0.41 from October 2017 and from memory they were saying $0.50 or so at one point after that. Back then the ARR was well under $10m. So two years later with the ARR over $40m the stock is worth half what it was when the ARR was under $10m. Yeah that makes sense - NOT!!
The other two brokers that cover it are worth listening to: Citi has a buy rating with a price target of $0.75 and Blue Ocean Equities has a buy rating with a price target of $0.80 and strategic target of $1.40.
Anyone relying on Wilsons for a view on LVT needs their head read!!
- Forums
- ASX - By Stock
- LVT
- Ann: Q1 ARR $42.9m, confirms strong outlook
Ann: Q1 ARR $42.9m, confirms strong outlook, page-117
-
- There are more pages in this discussion • 78 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add LVT (ASX) to my watchlist
|
|||||
Last
0.6¢ |
Change
0.000(0.00%) |
Mkt cap ! $6.474M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Featured News
LVT (ASX) Chart |
Day chart unavailable
The Watchlist
LGP
LITTLE GREEN PHARMA LTD
Paul Long, CEO
Paul Long
CEO
Previous Video
Next Video
SPONSORED BY The Market Online